Agenda - MedTech Summit 2026

08:00 Registration & Coffee

09:00  Welcoming remarks, BioStock

09:05 Beyond the Valley of Death

Jón Ingi Bergsteinsson, Founder & Managing Partner, LIFA Ventures & Founder & Chairman, IceBAN
Bita Sehat, Partner, Trill Impact
Magnus Holm, Venture Partner, Peppermint Venture Partners
Yun Yang, Investment Associate, Hadean ventures
Moderated by: Adam Rosenwach, Managing Partner, Star51 Capital 

Company presentations

09:45 Paindrainer, Carl Borrebaeck, Chairman
10:00 Reccan, Anna Brodén, CEO
10:15  Embla Medical, Klaus Sindahl, Head of IR

10:30 Coffee & Networking

10:55 The Next Chapter of Healthcare – Trend forecasting & interactive dialogue

The future of health is driven by smarter technology, personalized care, and real‑time insights. With advances in AI, digital tools, and connected devices, healthcare is becoming more proactive, accessible, and tailored to each individual. Discover the future of health with Nasim Farrokhia.

Nasim Bergman Farrokhnia is an experienced MD and PhD in medicine with a demonstrated history of working in the global healthcare and health tech ecosystem.. With a background spanning the Karolinska Institute, Kry and Microsoft, she has spent over 25 years driving progress at the intersection of medicine and technology.

Company presentations

11:30 Colzyx, Jens Hansson, Chairman
11:45 Optisense Care, Peter Rybäck, CEO
12:00 Medarca, Lars Malmgren, CEO

12:15 AI or Die? The brutal truth about winning in healthtech 

Daniel Karsberg, Partner, HealthCap
Magnus Bergman, Co-founder & General partner, Luminar Ventures
Frida Schain, Investment Manager, Sciety
Ruth Brännvall, CEO & GP, Impact invest
Moderated by: Marko Kuisma, Partner, Innovestor Life Science

12:55 Lunch & networking

13:55 Keynote Fireside chat: From musician to medtech VC : A personal journey with Adam Rosenwach

Adam Rosenwach, Managing Partner, Star 51 Capital
Felix Borrebaeck, Business Developer, BioStock

Company presentations

14:25 Sitisolv, Jörgen Gustafsson, CEO
14:40 Movesense, Jussi Kaasinen, CEO
14:55 Perpetua Medical, Anders Hedlund, CEO

15:10 Commercialisation – Winning MedTech Commercialisation Strategies

Karin Leire, Investment Director, Segulah Medical Acceleration
Hanna Sjöström, CEO, Neola Medical
Martin Stenfeldt, CEO, UNEEG medical
Anders Wallseth, Chairman, Starfish of Sweden
Anders Hedlund, CEO, Perpetua Medical
Moderated by: Malin Bornschein, CEO, Medeon science park

15:40 Coffee & networking

Company presentations

16:10 Rowdy Dynamics, Fredrik Jonsson, CEO
16:25 Suturion, Gabriel Börner, CMO & Founder
16:35 Sorbus Biomedical, Roger Rönn, CEO
16:40 Anatomic Studios

16:45  Cracking the Capital Code: Distinguishing the logics of VC from Family Office

Marie-Louise Little, Dir of Strategy & BD, T & W Medical
Jan Erik Smith, Partner, GOBIA Enterprises AB
Silke Sperling, Founding & Managing Partner, Catalpa Ventures
Laurent Pacheco, Managing Partner, International Family Office Alliance for Health (IFOAH) & Partner, Solas BioVentures

17:15 Concluding remarks

17:20 After work

Commercialisation – Winning MedTech Commercialisation Strategies

What does it take to bring a MedTech innovation from lab to market, and make it stick? This session dives into real-world commercialization strategies for different types of MedTech companies. We explore how to align your product with current healthcare workflows, how to tailor go-to-market plans per customer group, and why a regulatory strategy alone isn’t enough – you need a full commercialisation roadmap to succeed.

Karin Leire, Investment Manager, Segulah Medical Acceleration
Hanna Sjöström, CEO, Neola Medical
Martin Stenfeldt, CEO, UNEEG medical
Anders Wallseth, Board Member, Starfish of Sweden
Anders Hedlund, CEO, Perpetua Medical
Moderated by: Malin Bornschein, CEO, Medeon Science Park

Time on stage: 15:10

MedTech Summit panel about Commercialisation

Beyond the Valley of Death

In this panel, leading MedTech VCs debate what a next-generation investment model should look like. Are hybrid funds, non-dilutive capital stacks, and industrial co-development the way forward? Can new reimbursement-driven valuation models finally align risk and return? And what would it take to create a true “MedTech pacemaker” – a financing system that keeps companies alive long enough to reach patients?

Jón Ingi Bergsteinsson, Founder & Managing Partner, LIFA Ventures & Founder & Chairman, IceBAN
Magnus Holm, Venture Partner, Peppermint Venture Partners
Yun Yang, Investment Associate, Hadean ventures
Bita Sehat, Partner, Trill Impact
Moderated by: Adam Rosenwach, Managing Partner, Star 51 Capital

Time on stage: 09:05

AI or Die? The brutal truth about winning in healthtech

In this panel, leading investors debate whether companies that fail to meaningfully integrate AI are setting themselves up for failure – or whether the market is heading toward an AI bubble overdue for correction. Are we witnessing a true transformation of healthcare delivery, diagnostics, and operations, or simply the latest hype cycle where only a few will endure? We explore where AI genuinely creates defensible advantage, where it doesn’t, and when – or if – the hype is going to pop.

Daniel Karsberg, Partner, HealthCap
Magnus Bergman, Co-Founder & General partner, Luminar Ventures
Frida Schain, Investment Manager, Sciety
Ruth Brännvall, CEO & GP, Impact invest
Moderated by: Marko Kusima, Partner, Innovestor Life Science

Time on stage: 12:15

Learn more about the innovators at MedTech Summit 2026

Presenting Companies